Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs

Vaccine

Volumn 24, Issue 22, 2006, Pages 4769-4778

  Kimman, Tjeerd G ^a   Boot, Hein J ^a   Berbers, Guy A M ^a   Vermeer de Bondt, Patricia E ^a   Ardine de Wit, G ^a   de Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cost effectiveness; Disease; National immunization program; Pathogen; Vaccination; Vaccine; Vaccine preventable disease

Indexed keywords

VACCINE;

ARTICLE; CHECKLIST; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; IMMUNIZATION; IMMUNOSURVEILLANCE; MEDICAL DECISION MAKING; MICROBIAL POPULATION DYNAMICS; PATHOGENESIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SCIENTIFIC LITERATURE;

COST-BENEFIT ANALYSIS; DECISION MAKING; EVALUATION STUDIES; HUMANS; IMMUNIZATION PROGRAMS; NETHERLANDS; VACCINATION;

EID: 33646850584     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.022     Document Type: Article

References (31)

1. Schmitt H.-J., Booy R., Weil-Oliver C., van Damme P., Cohen R., and Peltola H. Child vaccination policies in Europe: a report from the summits of independent European vaccination experts. Lancet Infect Dis 3 (2003) 103-108
2. Abbink F., Buisman A.M., Doornbos G., Woldman J., Kimman T.G., and Conyn-van Spaendonck M.A.E. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis 191 (2005) 990-999
3. Asch-Goodkin J. For tomorrow's children: vaccines on the horizon. http://www.contpeds.com/be_core/content/journals/k/data/2004/0501/futureshot.html
4. Oxman M.N., Levin M.D., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
5. Erickson L.J., De Wals P., and Farand L. An analytical framework for immunization programs in Canada. Vaccine 23 (2005) 2468-2474
6. Boot HJ, De Melker HE, Stolk EA, De Wit GA, Kimman TG. Assessing the introduction of universal varicella vaccination in The Netherlands, submitted for publication.
7. Gruyer B., Hughart N., Holt E., et al. Immunization coverage and its relationship to preventive health care visits among inner-city children in Baltimore. Pediatrics 94 (1994) 3-58
8. Stratton K.R., Durch J.S., and Lawrence R.S. Vaccines for the 21st century. Institute of Medicine (2000), National Academy Press, Washington, DC US Department of Health; 2003
9. Principi N., and Esposito S. Are we ready for universal influenza vaccination in pediatrics?. Lancet Infect Dis 4 (2004) 75-83
10. de Neeling J.N.D. Kostenutiliteitsanalyse; onzekerheden beperken toepasbaarheid. Ned Tijdschr Geneesk 148 (2004) 1106-1110
11. Williams A., and Cookson R. Equity in health. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of health economics vol. I (2000), Elsevier, Amsterdam 1863-1910
12. Cohen J.U.S. Vaccine supply falls seriously short. Science 295 (2002) 1998-2001
13. Gangaroza E.J., Galazka A.M., Wolfe C.R., Philips L.M., Gangarosa R.E., Miller E., et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351 (1998) 356
14. Paulussen TGW, Lanting CI, Buijs GJ, et al. Ouders over het Rijksvaccinatieprogramma: tevredenheid en vaccinatiebereidheid van ouders van jonge kinderen in Nederland. TNO-rapport PG/JGD2000.033. Leiden, TNO Preventie en Gezondheid; 2000.
15. Balinska M.A. Vaccination in tomorrow's society. Lancet Infect Dis 3 (2003) 443-447
16. Gregson A.L., and Edelman R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol Allergy Clin North Am 4 (2003) 649-664
17. Gezondheidsraad: Algemene vaccinatie tegen meningokokken C en pneumokokken. Gezondheidsraad: Den Haag; 2001. publicatie nr 2001/27.
18. Halperin B.A., Eastwood B.J., and Halperin S.A. Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine. Pediatr Infect Dis J 17 (1998) 103-109
19. Woodin K.A., Rodewald L.E., Humiston S.G., Carges M.S., Schaffer S.J., and Szilagyi P.G. Physician and parent opinions. Are children becoming pincushions from immunizations?. Arch Pediatr Adolesc Med 149 (1995) 845-849
20. Mackinnon M.J., and Read A.F. Immunity promotes virulence evolution in a malaria model. PLoS Biol 2 (2004) E230
21. Lee C.W., Senne D.A., and Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78 (2004) 8372-8381
22. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 28 Suppl. 2 (1999) S112-S117
23. Mooi F.R., van Oirschot H., Heuvelman K., van der Heide H.G., Gaastra W., and Willems R.J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66 (1998) 670-675
24. Mooi F.R., van Loo I.H., and King A.J. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?. Emerg Infect Dis 7 (2001) 526-528
25. Brisson M., Edmunds W.J., and Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70 Suppl. 1 (2003) S31-S37
26. Howe M. Pneumococcal vaccination programme begins in Australia. Lancet Infect Dis 1 (2001) 69
27. Verweij M. Ethische uitgangspunten voor het collectieve vaccinatieprogramma. Infectieziekten Bulletin 11 (2000) 258-261
28. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 (2004) 1757-1765
29. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347 (2002) 1645-1651
30. McDonald J.C., Moore D.L., and Quennec P. Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease. Pediatr Infect Dis J 11 (1989) 751-755
31. MMWR. Suspension of rotavirus vaccine after reports of intussusception-United States. Morb Mortal Wkly Rep 53 (2004) 786-789